← Leaderboards
Gary J Nabel
National Institute Of Allergy And Infectious Diseases
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Institute Of Allergy And Infectious Diseases
Same institution · by research overlap
Others in their field
Top investigators on “Vaccines”
- Lawrence Corey · Fred Hutchinson Cancer Center$829,044,908
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$556,540,832
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$515,215,260
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
- Dennis R. Burton · Scripps Research Institute$316,106,418
Research focus
VaccinesImmune ResponseProteinsVectorVaccine DevelopmentVirusViral ProteinsHiv-1ViralInfluenzaImmunityAntibodiesAdenovirusesNeutralizing AntibodyT-LymphocyteRecombinantsInfection PreventionNonhuman PrimateInfectionVaccination StrategyHiv InfectionsGenetic VaccinePreventSerotyping
Grant awards (33)
HIV/AIDS Vaccine Development$6,479,015
ZIA · FY2012 · AI · contact PI
Modifications to improve HIV neutralizing antibodies$1,800,000
ZIA · FY2012 · AI · contact PI
Influenza Vaccine Development$1,695,001
ZIA · FY2012 · AI · contact PI
Recombinant Adenovirus Vector Vaccine Studies$1,495,002
ZIA · FY2012 · AI · contact PI
Development of Vaccines for Chikungunya and Other Alphaviruses$678,000
ZIA · FY2012 · AI · contact PI
AAV vectored vaccines$549,483
ZIA · FY2012 · AI · contact PI
Methods for Inhibiting Ebola Virus Replication$240,588
ZIA · FY2012 · AI · contact PI
Mechanisms Of HIV-1 Entry and Transfer to CD4+ T cells$220,670
ZIA · FY2012 · AI · contact PI
HIV/AIDS Vaccine Development$6,779,015
ZIA · FY2011 · AI · contact PI
Recombinant Adenovirus Vector Vaccine Studies$1,695,002
ZIA · FY2011 · AI · contact PI
Influenza Vaccine Development$1,695,001
ZIA · FY2011 · AI · contact PI
Development of Vaccines for Chikungunya and Other Alphaviruses$678,000
ZIA · FY2011 · AI · contact PI
Methods for Inhibiting Ebola Virus Replication$240,588
ZIA · FY2011 · AI · contact PI
Mechanisms Of HIV-1 Entry and Transfer to CD4+ T cells$225,517
ZIA · FY2011 · AI · contact PI
HIV/AIDS Vaccine Development$6,804,629
ZIA · FY2010 · AI · contact PI
Influenza Vaccine Development$1,701,158
ZIA · FY2010 · AI · contact PI
Recombinant Adenovirus Vector Vaccine Studies$1,701,158
ZIA · FY2010 · AI · contact PI
Development of Vaccines for Chikungunya$680,462
ZIA · FY2010 · AI · contact PI
Methods for Inhibiting Ebola Virus Replication$241,409
ZIA · FY2010 · AI · contact PI
Mechanisms Of HIV-1 Entry and Transfer to CD4+ T cells$226,822
ZIA · FY2010 · AI · contact PI
HIV/AIDS Vaccine Development$2,695,631
ZIA · FY2009 · AI · contact PI
The Mechanisms Involved in Ebola Glycoprotein Induced Cytotoxicity$1,475,675
ZIA · FY2009 · AI · contact PI
Influenza Vaccine Development$1,425,675
ZIA · FY2009 · AI · contact PI
Recombinant Adenovirus Vector Vaccine Studies$1,096,350
ZIA · FY2009 · AI · contact PI
Mechanisms Of HIV-1 Entry and Transfer to CD4+ T cells$570,316
ZIA · FY2009 · AI · contact PI
Development of Vaccines for Chikungunya$286,350
ZIA · FY2009 · AI · contact PI
Influenza Vaccine Development$1,489,572
Z01 · FY2008 · AI · contact PI
The Mechanisms Involved in Ebola Glycoprotein Induced Cytotoxicity$1,489,572
Z01 · FY2008 · AI · contact PI
HIV/AIDS Vaccine Development$1,162,466
Z01 · FY2008 · AI · contact PI
Recombinant Adenovirus Vector Vaccine Studies$1,069,851
Z01 · FY2008 · AI · contact PI
Development of Broad-Spectrum Antiviral Agents$839,875
Z01 · FY2008 · AI · contact PI
Mechanisms Of HIV-1 Entry and Transfer to CD4+ T cells via DC-SIGN$592,466
Z01 · FY2008 · AI · contact PI
Development of Vaccines for Chikungunya$271,897
Z01 · FY2008 · AI · contact PI